These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15270306)

  • 1. [Pathogenetic bases of cognitive and psychotic disorders in Parkinson's disease].
    Litvinenko IV; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):72-6. PubMed ID: 15270306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nonmotor signs of Parkinson's disease].
    Tavadian ZD; Bakunts GO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):81-5. PubMed ID: 25035883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review.
    Khan MA; Quadri SA; Tohid H
    Bull Menninger Clin; 2017; 81(1):53-105. PubMed ID: 28271905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementia and psychotic disorders in parkinsonism: common origin and new perspectives in therapy].
    Litvinenko IV
    Adv Gerontol; 2004; 13():94-101. PubMed ID: 15490731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis.
    Shergill SS; Walker Z; Le Katona C
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):610-1. PubMed ID: 9771806
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychotic disorders in Parkinson's disease and dementia with Lewy bodies].
    Levin OS; Anikina MA; Shindriaeva NN; Zimniakova OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):82-8. PubMed ID: 21905342
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric disturbances in Parkinson's disease.
    Celesia GG; Wanamaker WM
    Dis Nerv Syst; 1972 Sep; 33(9):577-83. PubMed ID: 4649149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mental dysfunction in Parkinson's disease].
    Růzicka E
    Cas Lek Cesk; 1996 Apr; 135(7):199-203. PubMed ID: 8681366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
    Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.
    Factor SA; Steenland NK; Higgins DS; Molho ES; Kay DM; Montimurro J; Rosen AR; Zabetian CP; Payami H
    Mov Disord; 2011 Oct; 26(12):2190-5. PubMed ID: 21714002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of non-motor symptoms in advanced Parkinson disease.
    Truong DD; Bhidayasiri R; Wolters E
    J Neurol Sci; 2008 Mar; 266(1-2):216-28. PubMed ID: 17804018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of cognitive functions in Parkinson's disease].
    Mildworf B; Globus M; Melamed E
    Harefuah; 1986 May; 110(10):501-3. PubMed ID: 3758849
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis.
    Voss TS; Brocht AF; Ravina B
    Mov Disord; 2010 Jan; 25(1):124-5. PubMed ID: 19412941
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV
    Rev Neurol; 2001 Jun 16-30; 32(12):1182-7. PubMed ID: 11562851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision.
    Bodis-Wollner IG; Paulus W
    Adv Neurol; 1999; 80():383-8. PubMed ID: 10410745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.